InStride Health, a pioneering provider of pediatric anxiety and Obsessive Compulsive Disorder (OCD) treatments, has secured a monumental $30M in Series B funding. Under CEO John Voith's leadership, this Boston-based organization is setting new standards in mental health care for adolescents.